BeStock  
Markets › Compare › INCY vs ALNY

INCY vs ALNY

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
INCY · Incyte$118.65 ▼ 2.23%
ALNY · Alnylam Pharmaceuticals$236.13 ▼ 4.30%

Head to head

MetricINCYALNY
Price$118.65$236.13
Change today▼ 2.23%▼ 4.30%
Market cap$24.05B$31.60B
Return, 3 months+4.3%–
Return, year to date+20.1%–
Return, 1 year+36.9%–
P/E (TTM)15.141.1
P/B3.823.3
P/E percentile vs own 5y7th84th
Dividend yield––
Revenue growth (YoY, latest qtr)+37.7%+66.9%
Net profit growth (YoY)+44.6%+327.7%
Gross margin92.6%79.7%
Operating margin31.6%20.8%
Net margin27.7%16.1%
Return on equity30.7%96.6%
Analyst target vs. price+18.6%+56.7%
Analyst buy share79%86%
RSI (14)44–
30-day volatility26.3%–
Max drawdown, 1 year-18.3%–
Trend readLeaning bearish–
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ALNY is the largest of the group by market value.
  • INCY carries the lowest trailing P/E.
  • ALNY is growing revenue fastest.
  • INCY keeps the most profit per dollar of sales.

Go deeper

Scroll to Top